Source:http://linkedlifedata.com/resource/pubmed/id/15225732
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2004-6-30
|
pubmed:abstractText |
A series of 3-O-acyl, 3-hydrazine, 2-bromo, and 20,29-dibromo betulinic acid derivatives (1-27) have been synthesized and screened for in vitro cytotoxic activity on human cancer cell lines MOLT-4, JurkatE6.1, CEM.CM3, BRISTOL8, U937, DU145, PA-1, A549, and L132. A number of compounds have shown ED(50)<1 microg/mL against the cancer cell lines tested and have shown better cytotoxicity than betulinic acid. Compounds 13, 19, 20, 23, and 27 were the best derivatives and were selected as lead molecules for further development. The structure-activity relationship has been described.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4087-91
|
pubmed:meshHeading |
pubmed-meshheading:15225732-Antineoplastic Agents,
pubmed-meshheading:15225732-Cell Line,
pubmed-meshheading:15225732-Cell Line, Tumor,
pubmed-meshheading:15225732-Cell Survival,
pubmed-meshheading:15225732-Humans,
pubmed-meshheading:15225732-Hydrazines,
pubmed-meshheading:15225732-Jurkat Cells,
pubmed-meshheading:15225732-Models, Molecular,
pubmed-meshheading:15225732-Molecular Conformation,
pubmed-meshheading:15225732-Triterpenes
|
pubmed:year |
2004
|
pubmed:articleTitle |
Synthesis and cytotoxic activity of 3-O-acyl/3-hydrazine /2-bromo/20,29-dibromo betulinic acid derivatives.
|
pubmed:affiliation |
Division of Experimental Oncology, Dabur Research Foundation, 22, Site IV, Sahibabad, Ghaziabad 201 010, UP, India.
|
pubmed:publicationType |
Journal Article
|